Aspirin Resistance and Adverse Clinical Events in Patients with Coronary Artery Disease
- 1 July 2007
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 120 (7), 631-635
- https://doi.org/10.1016/j.amjmed.2006.10.021
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Low-dose aspirin increases aspirin resistance in patients with coronary artery diseaseAmerican Journal Of Medicine, 2005
- Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASAThe American Journal of Cardiology, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001
- Platelet-Active DrugsChest, 2001
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993